Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
NCT02637232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 301
Last updated 2021-05-28
Summary
The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.
Conditions
- Rosacea
Interventions
- OTHER
-
Mirvaso® / Onreltea TM
Sponsors & Collaborators
-
Chiltern International Inc.
collaborator INDUSTRY -
Galderma R&D
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- Canada
Study Locations
More Related Trials
-
Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea
NCT03508869 ·Status: TERMINATED ·Phase: NA
-
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
NCT02616250 ·Status: COMPLETED ·Phase: PHASE4
-
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
NCT02393937 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea
NCT06582043 ·Status: COMPLETED ·Phase: NA
-
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
NCT02602470 ·Status: COMPLETED
-
Assessment of Rosacea Patients' Clinical Trial Experiences
NCT05747391 ·Status: NOT_YET_RECRUITING
-
Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea
NCT02385240 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
NCT01872715 ·Status: COMPLETED ·Phase: PHASE4
-
MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3
NCT04059523 ·Status: COMPLETED ·Phase: PHASE1
-
A Twelve Week Safety and Efficacy Study in Rosacea
NCT01784133 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea
NCT06307288 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea
NCT03689010 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
NCT02576860 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Benefit of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin
NCT04898582 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
NCT02576847 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Low-Energy 1064nm Laser and DPL in Rosacea Treatment
NCT06915636 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea
NCT02120924 ·Status: COMPLETED ·Phase: PHASE3
-
Patient-Reported Outcome Of Facial Erythema (PROOF)
NCT01885000 ·Status: COMPLETED ·Phase: PHASE3
-
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
NCT02144181 ·Status: COMPLETED ·Phase: NA
-
A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea
NCT01614743 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea
NCT03287791 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
NCT00668655 ·Status: COMPLETED
-
A Safety and Efficacy Study of DRM02 in Subjects With Rosacea
NCT01993446 ·Status: COMPLETED ·Phase: PHASE2
-
M89PF in Rosacea Associated With Erythema and Sensitive Skin
NCT05562661 ·Status: COMPLETED
-
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
NCT01426269 ·Status: COMPLETED ·Phase: PHASE4